BioHorizons adds the IntraSpin™ system, the only FDA-cleared medical device for the production of PRF
BioHorizons is pleased to announce the addition of the IntraSpin system to our product portfolio. The IntraSpin system is the only FDA-cleared medical device for the chairside production of Platelet-Rich Fibrin (PRF). The IntraSpin centrifuge, manufactured in Germany, is a high-quality medical device with a quality guarantee. The IntraSpin system comes with specifically designed blood tubes that have also been FDA-cleared for the creation and implantation of PRF membranes.
PRF is increasingly being used in grafting procedures to enhance the healing process. The IntraSpin simple, three-step protocol produces a thin, compressed layer of Leukocyte Platelet-Rich Fibrin (L-PRF™) that is strong, pliable and suitable for surgical manipulation and suturing. The L-PRF matrix can act as a carrier for particulate bone material to improve handling characteristics. The IntraSpin system doesn’t require anti-coagulants, additives, second spin or heating and has been documented in over 200 clinical studies.
“I knew this was the perfect enhancement to our Biologics comprehensive portfolio and the addition of the IntraSpin system represents BioHorizons continued commitment to identifying novel solutions to enhance practices’ clinical outcomes,” said Steve Boggan, President and CEO of BioHorizons.
BioHorizons is offering courses across the United States for practitioners to learn more about this technology and to gain hands-on experience.
BioHorizons is a leading global provider of dental implants and tissue regeneration products for dentists and dental specialists. The company has a broad product offering; including dental implants, guided surgery, digital restorations and tissue regeneration solutions for the replacement of missing teeth. BioHorizons products are available in 90 markets around the world. For more information, visit biohorizons.com.